Gene-Tailored Drug Concept Extends from Cetuximab to Platelet Inhibitors
David W. Sharp
Gene-Tailored Drug Concept Extends from Cetuximab to Platelet Inhibitors
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 | 〉 |